1. Home
  2. PSMT vs IMVT Comparison

PSMT vs IMVT Comparison

Compare PSMT & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PriceSmart Inc.

PSMT

PriceSmart Inc.

HOLD

Current Price

$126.09

Market Cap

4.0B

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$22.81

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSMT
IMVT
Founded
1994
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.0B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
PSMT
IMVT
Price
$126.09
$22.81
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$27.71
AVG Volume (30 Days)
153.3K
1.2M
Earning Date
01-07-2026
11-10-2025
Dividend Yield
2.00%
N/A
EPS Growth
5.57
N/A
EPS
4.82
N/A
Revenue
$5,270,094,000.00
N/A
Revenue This Year
$10.66
N/A
Revenue Next Year
$9.64
N/A
P/E Ratio
$26.09
N/A
Revenue Growth
7.25
N/A
52 Week Low
$81.25
$12.72
52 Week High
$129.16
$29.49

Technical Indicators

Market Signals
Indicator
PSMT
IMVT
Relative Strength Index (RSI) 60.01 51.45
Support Level $123.95 $21.93
Resistance Level $129.16 $23.51
Average True Range (ATR) 3.23 0.90
MACD 0.50 -0.23
Stochastic Oscillator 75.87 35.16

Price Performance

Historical Comparison
PSMT
IMVT

About PSMT PriceSmart Inc.

Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: